A modified mouse model of Friedreich's ataxia with conditional

Friedreich's ataxia animal models cardiac diseases genetic diseases

Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 1 12 2023
pubmed: 1 12 2023
entrez: 1 12 2023
Statut: aheadofprint

Résumé

Friedreich's ataxia (FA) is an autosomal recessive disorder caused by a deficiency in frataxin (FXN), a mitochondrial protein that plays a critical role in the synthesis of iron sulfur clusters (Fe-S), vital inorganic cofactors necessary for numerous cellular processes. FA is characterized by progressive ataxia and hypertrophic cardiomyopathy, with cardiac dysfunction as the most common cause of mortality in patients. Commonly used cardiac-specific mouse models of FA utilize the muscle creatine kinase (MCK) promoter to express Cre recombinase in cardiomyocytes and striated muscle cells in mice with one conditional

Identifiants

pubmed: 38038720
doi: 10.1152/ajpheart.00496.2023
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tyler L Perfitt (TL)

Pfizer, Cambridge, MA, United States.

Claudia Huichalaf (C)

Pfizer, United States.

Renea Gooch (R)

Pfizer, Cambridge, United States.

Anna Kuperman (A)

Pfizer, United States.

Youngwook Ahn (Y)

Pfizer, United States.

Xian Chen (X)

Comparative Medicine, Pfizer Inc., Cambridge, MA, United States.

Soumya Ullas (S)

Pfizer, United States.

Dinesh Hirenallur-Shanthappa (D)

Comparative Medicine, Pfizer Inc., Cambridge, MA, United States.

Yutian Zhan (Y)

Pfizer, United States.

Diana Otis (D)

Pfizer, United States.

Laurence O Whiteley (LO)

Pfizer, Boston, United States.

Christine Bulawa (C)

Pfizer, United States.

Alain Martelli (A)

Pfizer Research and Development, Pfizer, Paris, France.

Classifications MeSH